rfxcel Corporation, a customer-focused serialisation and track and trace provider for the Life Sciences industry, announced today that DCC Vital, a manufacturer headquartered in Dublin, Ireland, has selected rfxcel to meet its European Falsified Medicines Directive (EU FMD) serialisation requirements.
As a European manufacturer of pharmaceuticals and medical devices, and a logistics provider in the UK, DCC Vital prides themselves in their ability to deliver solutions that will make a difference to patient care. Over the past 5 years, DCC Vital has more than doubled the scale of their business to create a focused support system for their customers in Europe, and most recently have been gaining an increased presence worldwide. As DCC Vital continues to expand their footprint internationally, the company needed a serialisation platform that could accommodate their diverse product offering, understand the need to keep their customers at the top of their focus, and allow them the flexibility to manage their environment based on their specifications.
“DCC Vital selected rfxcel for 3 reasons,” said Conor O'Shea, DCC Vital’s Head of Information Technology. “First, rfxcel is easy to work with. Throughout the evaluation process, rfxcel was very responsive and provided clear answers to our questions. Second, rfxcel offers a simple pricing model that is straight forward & transparent. Finally, rfxcel offers a customer focused architecture that allows us to manage a validated environment according to our quality standards and schedule.”
Relentless commitment to customer success and continuous innovation ensures that rfxcel’s customers meet their requirements and protect their consumers. “We are seeing a paradigm shift in the industry through recent competitive conversions, due to a lack of personalized attention from vendors.” said Glenn Abood, CEO of rfxcel. “Manufacturers and the entire supply chain desire timely response, support, control, and pricing transparency from their solution providers.”
rfxcel offers fixed bid contracts, which ensures customers a clear insight into their pricing model, which is not the case when contracts are based on time and material bids. “Customers are realizing that compliance with the FMD is just the starting point. In digitizing their complex supply chains, they are seeking out partners such as rfxcel who are willing to work with their specific needs and ways of working. We help customers to succeed, without imposing inflexible processes or the frequent changes, risk assessments and re-validations involved with other vendors,” said Mark Davison, Senior Director of Operations Europe.
Macallan Whisky picks Izon® Technology as part of a comprehensive anti-counterfeit solution
(De La Rue Authentication Solutions)
The Edrington Group, makers of world renowned The Macallan Highland Single Malt Scotch Whisky, faced a challenge when re-filled used
bottles, intact with labels, began appearing on shelves under their brand name. This posed a serious consumer safety, as well as a global
brand issue. For a solution, they turned to Authentication Solutions for the key overt component of a comprehensive solution.
Epson builds market awareness of authentic product through implementation of layered AC tech
(De La Rue Authentication Solutions)
Epson Latin America estimated that 20% of the product in the market was counterfeit and entering the supply chain through local distributors. The existing anti-counterfeiting ink technology was compromised. Epson developed a new strategy to target unauthorized distributors in key countries and build market awareness of authentic product.
The StellaGuard™ solution leverages the benefits of a barcode and connects it with a three-dimensional visual reference that provides instantaneous authentication with copy-detect protection. StellaGuard™ is a patented and elegant solution to protect your assets, enabling trusted stakeholders, including customers, to authenticate a product using common everyday smart devices.
The smartphone: a new tool to spot fake products
The development of new smartphone technologies offers brands the opportunity to fight counterfeiting more efficiently and drive competitive differentiation by turning their products into smart assets. This paper examines the process of placing the consumer as one of the key actors against illicit trade and creating new business intelligence capabilities for brands.
Pharma Security World 2018: "Anti-counterfeiting and Brand Safety"
March 20-21, 2018 - London, UK
Global Illicit Trade Summit 2018: Out of the shadows
March 22, 2018 - Kuala Lumpur
4XScience 2018 E2E Supply Chain Serialization Benchmark Workshop
March 27-28, 2018 - Brussels, Belgium
Robert Schuman Foundation conference: Smuggling, counterfeiting and the financing of terrorism – mobilising economic stakeholders
April 11, 2018 - Brussels, Belgium
April 17-19, 2018 - New York (NY), USA
4th Global Brand Protection EU Innovation Programme (GBPIP)
April 26-27, 2018 - London, UK
IACC 2018 Annual Spring Conference
May 16-18, 2018 - Seattle (WA), USA
INTA Annual Meeting
May 19-23, 2018 - Seattle (WA), USA
May 29 - June 01, 2018 - Milan, Italy
Partnership for Safe Medicines 2018 Interchange
June 07, 2018 - Washington D.C., USA
June 25-27, 2018 - London, UK
September 2018 (dates tbc) - Switzerland
Rx-360 Global Life Science Supply Chain 2018 Conference: Driving Innovative Quality Strategies
September 25-26, 2018 - Miami (FL), USA
2018 A-CAPP Center Brand Protection Strategy Summit
October 02-03, 2018 - East Lansing (MI), USA
13th Security Document Summit (SDS)
October 17-18, 2018 - Beijing, China
Anti-Counterfeit & Currency Expo (ACCE)
November 06-08, 2018 - Las Vegas (NV), USA